Business
Please quote reference number B07640.

The company’s wholesale arm specialises in the distribution of non-prescription medical devices for both medics and non-medic aesthetics professionals, including but not limited to dermal fillers, fat dissolvers, PDO threads, skin boosters, etc. The company’s pharma arm is a fully-regulated GPhC- and MHRA-compliant pharmacy, specialising in non-NHS private prescriptions of specialist aesthetics treatments to medical and non-medical professionals.

Offered for sale are the two powerhouse wholesale and pharma businesses behind a growing aesthetics group established several years ago. Together, the businesses generated over £7.7 million in sales and £473,191 in adjusted EBITDA in 2023, demonstrating a strong and growing market presence.

The wholesale arm specialises in the distribution of non-prescription medical devices for both medics and non-medic aesthetics professionals, including but not limited to dermal fillers, fat dissolvers, PDO threads, skin boosters, etc. It has quickly grown to become one of the industry’s largest retailers, averaging over 100 orders daily.

In 2022, the group strengthened its offering by becoming a trusted distribution partner for leading aesthetics brands like Monalisa dermal filler, Singderm dermal filler, Extra by KLMEDI dermal filler, and EpLine PDO thread, providing customers with access to a wide range of high-quality products.

The pharma arm is a fully-regulated and GPhC- and MHRA-compliant pharmacy, specialising in non-NHS private prescriptions of specialist aesthetics treatments to medical and non-medical professional. It is currently undergoing approval for an international Wholesale Distribution Authorisation (WDA) licence to allow wholesale deals, which promises to significantly boost revenue. 

The company benefits from a qualified Superintendant Pharmacist who oversees the pharmacy’s day-to-day operations, while ensuring GPhC and MHRA compliance.   

Together, the pharmacy and wholesale facility fulfil 1000 orders per week.  

Highlights – 

• Direct contracts with leading suppliers, resulting in a cost-effective supply chain and strong profit margins, exceeding 20% per item.
• Trusted distribution partner for brands such as Monalisa dermal filler, Singderm dermal filler, Extra by KLMEDI dermal filler, and EpLine PDO thread.
• A 5,000-strong returning client base, with approximately 1000 orders fulfilled weekly.
• In-place business Superintendant Pharmacist, ensuring GPhC and MHRA compliance.
• Excellent national and international reach facilitated by a strong digital presence and the company’s own e-commerce sales platforms.
• Formidable financial profile with significant year-over-year revenue growth – from £3.4m in 2022 to £7.7m in 2023.

Opportunities – 

Pending international WDA license for the pharma arm promises significant revenue growth, while P-licensed products and a beauty product line offer opportunities for portfolio diversification.

Location
The business is located in the North West.

Premises
The business operates from two leasehold units .

Tenure
The business premises are Leasehold.

Hours
The business operates all year round.

Staff
The business has a team of qualified staff with varying degrees of experience.

Financial Profile
Turnover IRO – £7.7m in 2023

• 100% share capital.
• Interested parties to sign an NDA.
• Leasehold premises available.